Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis
about
Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosisThe pathology of multiple sclerosis and its evolutionPercutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patientsPercutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patientsNatalizumab for relapsing remitting multiple sclerosisComprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseasesExpression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patientsTheiler's virus infection: a model for multiple sclerosisBrain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?Multiple sclerosisBiomarkers of therapeutic response in multiple sclerosis: current statusGain of Olig2 function in oligodendrocyte progenitors promotes remyelination.A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 casesAntibody biomarkers in CNS demyelinating diseases - a long and winding roadHeterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelinationDiagnostic biomarkers in multiple sclerosis.Cerebral plasticity in multiple sclerosis: insights from fMRI.Advanced MRI and staging of multiple sclerosis lesions"Clues on Balo's concentric sclerosis evolution from serial analysis of ADC values".Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis.Clinical-magnetic resonance imaging correlations in multiple sclerosis.Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity.Progress in determining the causes and treatment of multiple sclerosis.Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.Absence of spontaneous central nervous system remyelination in class II-deficient mice infected with Theiler's virus.Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.Therapeutic strategies in multiple sclerosis. I. ImmunotherapyInfluence of type I IFN signaling on anti-MOG antibody-mediated demyelination.Apoptosis in human autoimmune diseases.Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis.Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis.Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays.A novel microtubule-associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions.A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.Drug treatment of multiple sclerosisChanges in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.Chemokine receptor antagonism as a new therapy for multiple sclerosis.Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.Proteomic analysis of cerebrospinal fluid in a fulminant case of multiple sclerosis.Glial cells as targets for cytotoxic immune mediators.
P2860
Q21144285-E0D10E83-CE0D-4246-B71B-E1C5FDE00811Q22242676-4A7E0F6B-4C23-48C8-B97C-16D8A5BADD13Q24202111-8C5A7C37-92CF-4B7D-A712-A5D5BE2A8847Q24202967-994AED1E-5073-405F-AFCF-B5F3AF86A237Q24235861-D0701438-64E2-4EFC-B0B8-36E19B6AC22FQ24273331-4C44A4A8-C92E-4CE0-B3B3-4B2F70F484F4Q24563395-0E949A5E-35AB-4BCB-B900-73811C6A5A99Q24629115-AEAFD4ED-DAC0-4022-8AE0-6632B8F339D4Q26799233-45557EAA-E8A4-444B-AB96-BEA9ED50C2B3Q26995437-FF0F5B7D-D359-4B88-A323-7331E0919E43Q27012726-64AA5C2E-6B76-4FCE-B59D-DD2061EC9916Q27303918-8B34FDCB-5427-479B-A59B-E5159B739F61Q28139227-2D9F3F8C-304B-41A7-895A-8B6F12CABD61Q28262403-8C29873B-780B-4566-B512-9ACE5BE987E2Q29614990-CF157297-F0BA-4FEF-9A9D-32DF2F466781Q30598338-4487319F-4325-4F50-A827-4C276B577D29Q30704521-A7E73D87-8A35-4AC7-8F62-78877C2A8828Q30825494-66B03E49-5E5B-4987-A078-65A69DEA2CD3Q30870400-F0CC04FC-3A18-4C82-8C83-349B8BDDD0D7Q31017620-2B266FA9-D200-4B50-8E8C-E71200FAB09BQ31027945-783ABAAA-BFCD-4AFC-99D3-76F6F87B3580Q33630981-95296335-6F43-49F4-85AF-D25052402455Q33678174-E8A9F9E2-5803-4FD2-9CC5-49954FFC88B2Q33722349-CC5C7695-065C-465B-BDE0-0C5859E1C7B5Q33727410-C38B2269-42C2-4AD3-9E87-7D5DFAB83207Q33740931-4E318CFB-2E14-424B-BC7A-B98FE15DA91BQ33798254-72F26F92-C04C-48FC-8CB8-71433A49B451Q33831179-7A574EEC-2952-494D-8E4A-7BC3A46AC7DCQ33836352-5D61AAEF-6D19-4A28-B03A-DA552802684EQ33839043-44DB7AFE-F95B-4756-8A65-0D65465B8D1BQ33862720-81036671-359F-429B-9B8D-CCC769B6C4D3Q33873680-FA02785C-9834-44D7-B746-AEB64A80A946Q33882319-7363B6EB-6F66-4495-A2B4-FAAB48020F40Q33882987-D3604A73-4EC8-41C8-A0B5-A548C54F4229Q34007633-203C2719-ECE4-49FF-A63F-360B93D28513Q34052870-2521B36F-DD86-4E65-952B-8833D1B10EF3Q34074854-AC933663-9D67-4D62-8C2F-DFAAC93C6D7AQ34118301-2587D5BB-D749-432C-8FBE-CF7156FCC7ACQ34353773-AEAE8FA5-40BB-49AF-97EA-1DF4DA25C4C4Q34398657-ADA79399-2855-4D2F-9CAF-3D98A9738C39
P2860
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis
@ast
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis
@en
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis
@nl
type
label
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis
@ast
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis
@en
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis
@nl
prefLabel
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis
@ast
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis
@en
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis
@nl
P2093
P2860
P921
P1433
P1476
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis
@en
P2093
C F Lucchinetti
H Lassmann
M Rodriguez
P2860
P304
P356
10.1111/J.1750-3639.1996.TB00854.X
P407
P577
1996-07-01T00:00:00Z